A Peptide-based Vector for Efficient Gene Transfer In Vitro and In Vivo

• Published in: Molecular therapy 2011-08, Vol.19 (8), p.1457-1467
• Main Authors: Lehto, Taavi, Simonson, Oscar E, Mäger, Imre, Ezzat, Kariem, Sork, Helena, Copolovici, Dana-Maria, Viola, Joana R, Zaghloul, Eman M, Lundin, Per, Moreno, Pedro MD, Mäe, Maarja, Oskolkov, Nikita, Suhorutšenko, Julia, Smith, CI Edvard, Andaloussi, Samir EL
• Format: Article
• Language: English
• Subjects: Animals; Biological Transport; Cell Line; Cell-Penetrating Peptides - metabolism; Cricetinae; Cricetulus; Drug Carriers; Drug Delivery Systems; Endosomes - metabolism; Gene expression; Gene therapy; Gene Transfer Techniques; Genetic Therapy - methods; Genetic Vectors; Humans; Laboratories; Medicin och hälsovetenskap; Mice; Mice, Inbred BALB C; Nanoparticles; Nucleic Acids - metabolism; Original; Particle size; Peptides; Plasmids; Plasmids - metabolism; Toxicity; Transfection - methods; Vectors (Biology)
• ISSN: 1525-0016; 1525-0024; 1525-0024
• DOI: 10.1038/mt.2011.10

Finding suitable nonviral delivery vehicles for nucleic acid–based therapeutics is a landmark goal in gene therapy. Cell-penetrating peptides (CPPs) are one class of delivery vectors that has been exploited for this purpose. However, since CPPs use endocytosis to enter cells, a large fraction of peptides remain trapped in endosomes. We have previously reported that stearylation of amphipathic CPPs, such as transportan 10 (TP10), dramatically increases transfection of oligonucleotides in vitro partially by promoting endosomal escape. Therefore, we aimed to evaluate whether stearyl-TP10 could be used for the delivery of plasmids as well. Our results demonstrate that stearyl-TP10 forms stable nanoparticles with plasmids that efficiently enter different cell-types in a ubiquitous manner, including primary cells, resulting in significantly higher gene expression levels than when using stearyl-Arg9 or unmodified CPPs. In fact, the transfection efficacy of stearyl-TP10 almost reached the levels of Lipofectamine 2000 (LF2000), however, without any of the observed lipofection-associated toxicities. Most importantly, stearyl-TP10/plasmid nanoparticles are nonimmunogenic, mediate efficient gene delivery in vivo, when administrated intramuscularly (i.m.) or intradermally (i.d.) without any associated toxicity in mice.